AI4LUNGS 3rd Edition Newsletter!
Greetings from the AI4LUNGS project, welcome to our third edition of the Newsletter!
In the first half of 2025, the project has reached great achievements! With the kick start of the new project activities focusing on the platform, digital twin service, and User Experience (UX), the 3rd Stakeholder Forum online session held, and several conference attendances, we are excited to share with you all this information!
Let’s start off with the project updates!
​
Project Update
Kicking Off the AI4LUNGS Platform: Smarter Tools for Better Care
The development of the AI4LUNGS digital platform is officially underway! Led by KPMG Israel and supported by technical and clinical partners, this work package is building a powerful and practical tool with the goal to help healthcare professionals make faster, more accurate decisions when treating patients with complex lung conditions.
To do this, AI4LUNGS is collecting more than 2500 real-world patient records from our clinical partners (safely and following the privacy regulations) and turning them into smart insights. The platform will feature a user-friendly dashboard designed with doctors in mind and include an AI-powered “digital twin” system that can simulate different patient scenarios, offering tailored treatment suggestions based on real data.
Behind the scenes, our partners have carefully planned each step and addressed potential risks to keep everything on track.
​
Updates on the Stakeholder Forum
The AI4LUNGS Stakeholders Forum brings together clinicians, researchers, policymakers, hospital administrators, and IT specialists who share a common goal: transforming respiratory healthcare through the power of AI. In the past months, 2 Stakeholder Forum Sessions were held on the 7th of February and the 20th of May.
​
The 2nd Stakeholders’ Forum Clinical Validation Workshop focused on validating and refining the end-user requirements of the project platform through structured feedback from the members of the Forum. Read more about the workshop here.
​
The 3rd Online Stakeholder Forum Session was led by Reichman University. The participants explored the psychology behind successful physician & AI collaboration. The session focused on designing intuitive, human-centered interfaces that support trust, engagement, and usability for clinicians interacting with AI tools. Read more about the workshop here.
​
If you want to participate in the future online session, join the Stakeholder Forum here.
​
Create Synergies with AI4LUNGS
​
AI4LUNGS is excited to introduce the synergies we created with other Horizon projects that are working in the healthcare sector! We are currently in contact with more EU projects, and we would like to introduce the first 4 projects: Microb-AI-ome Project , CoMPaSS-NMD , COMFORT-EU , and ONCOVALUE ! Check out more information on our synergy page: https://www.ai4lungs.eu/synergies.
If you want to be part of our synergy, to shape the future of healthcare together, please contact the dissemination leader Emma Tsai at emma@futureneeds.eu
What is the EU AI Act? Training with the Partners
As AI4LUNGS advances towards deploying clinically supportive AI tools, understanding the legal landscape becomes essential. Magdalena Kogut - Czarkowska and Marta WiliÅ„ska from Timelex, AI4LUNGS’ legal partner, break down the implications of the EU Artificial Intelligence Act (AI Act) during an online training with the partners. They explained:
-
How the Act applies to research projects like AI4LUNGS
-
What will change once AI tools are brought to market, and why early compliance is key to developing responsible and legally sound AI in healthcare.
It is important for the project to consider compliance with the EU AI Act early on, to avoid future compliance burdens.
Read more information here.
​
Conference Attendance
From the start of 2025 till June, AI4LUNGS was presented at four conferences.
.png)
1st Porto Precision Cancer Meeting
José Carlos Machado from our partner i3S - Instituto de Investigação e Inovação em Saúde took part in the 1st Porto Precision Cancer Meeting on 16 January 2025, hosted by IPATIMUP. The event focused on liquid biopsies in cancer diagnostics and the growing role of AI in precision medicine. AI4LUNGS was highlighted as a promising initiative for advancing AI-driven innovations in cancer diagnosis and personalised care.
​
Read the full article here.
​
Women in Business and Beyond Conference
AI4LUNGS was presented by the communication and dissemination leader Anna Palaiologk and Emma Tsai from Future Needs during the Women in Business and Beyond Conference. The Conference, hosted in Limassol Cyprus, was empowering women in fields that are often male dominated. Being a project in the STEM, AI4LUNGS showcased our many female scientists in the decision making of the project, shaping the development of AI4LUNGS.
​
Read the full article here.
​
2025 Privacy Symposium Conference
At the 2025 Privacy Symposium in Venice, Magdalena Kogut-Czarkowska from Timelex, AI4LUNGS’ legal partner, joined the “AI for Health” panel to present Legal Challenges in Developing AI for Healthcare. She highlighted how the project is navigating complex regulatory landscapes, including the GDPR, European Health Data Space, and EU AI Act.
​
With AI4LUNGS aiming to support clinical decision-making, understanding obligations for high-risk AI systems is crucial: from data governance and transparency to conformity assessments for potential medical device classification.
​
Read the full article here.
​
HIMSS Global Health Conference and Exhibition
Our communication and dissemination leader, Future Needs, represented by Thanos Arvanitidis and Egle Joneliunaite, attended HIMSS Europe in Paris in June 2025. During the event, our partners introduced AI4LUNGS to conference attendees by distributing printed leaflets, engaging in discussions about AI in healthcare, and sharing the project’s latest achievements.
​
Read the full article here.
Building Ethical AI Solutions in Health Care: The AI4LUNGS Digital Ethics Principles
How can we ensure AI solutions in healthcare uphold the highest ethical and legal standards? Marcel Rebbert and Isabelle Schlegel from Deloitte, together with Magdalena Kogut from Timelex, present the AI4LUNGS Digital Ethics Principles —seven core guidelines that safeguard patient data, promote fairness and transparency, and ensure robust human oversight in AI development.
​
Read the full article here.
​
Early-Stage Non-Small Cell Lung Cancer (NSCLC)
In an article contributed by Dr. Alexandre Martínez Martín and Dr. Ilaria Priano of the Lung Cancer Oncologist Unit at Vall d’Hebron Institute of Oncology (VHIO), we explore the evolving treatment strategies for early-stage non-small cell lung cancer (NSCLC). The piece highlights the critical role of precision medicine, molecular analysis, and multidisciplinary collaboration in improving outcomes for resectable NSCLC.
​
Read the full article here.
Blogs
What’s Coming Up Next?
🇩🇪 Road to Germany 2025 🇩🇪
To celebrate the milestones achieved and to be forward-looking into the next steps of the project, the AI4LUNGS consortium partners are going to meet in Germany in February 2025. We are excited to see how the project is going to progress, and to leverage on the achievements for reaching the next milestones on the way!
As we continue to change the game in lung health in the AI4LUNGS project, collaboration and careful planning remain at the heart of our efforts. By fostering strong communication among partners and adhering to ethical and legal best practices, we are paving the way for impactful AI-driven innovations in healthcare.
​
Stay tuned for more updates as we achieve key milestones and progress toward our shared goal of transforming lung disease diagnostics and treatment.
From all of us at AI4LUNGS, we wish you a joyful holiday season and a bright start to the new year!🎅
Funded by the European Union under Horizon Europe Programme (Grant Agreement No. 101080756). Views and opinions expressed are however those of the AI4Lungs consortium author(s) only and do not necessarily reflect those of the European Union or the Health And Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.